We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK and Theravance Submit NDA On Respiratory Drug Candidate
GSK and Theravance Submit NDA On Respiratory Drug Candidate
July 20, 2012
GlaxoSmithKline (GSK) and Theravance have submitted applications in the U.S. and European Union (EU) for a new chronic obstructive pulmonary disease (COPD) and asthma treatment.